Published in Kidney Int Suppl on June 01, 1993
Measurement of hemodialysis vascular access flow using extracorporeal temperature gradients. Kidney Int (2007) 1.49
Isothermic hemodialysis and ultrafiltration. Am J Kidney Dis (2000) 1.39
Pharmacokinetics of azlocillin in persons with normal and impaired renal functions. Antimicrob Agents Chemother (1978) 1.28
Sum of segmental bioimpedance analysis during ultrafiltration and hemodialysis reduces sensitivity to changes in body position. Kidney Int (1999) 1.19
Overestimation of hemodialysis dose depends on dialysis efficiency by regional blood flow but not by conventional two pool urea kinetic analysis. ASAIO J (1996) 1.15
Priapism during regular haemodialysis. Lancet (1974) 1.14
Clonal composition of human adrenocortical neoplasms. Cancer Res (1994) 1.10
[Significance of bladder puncture in the nephrological diagnosis]. Med Welt (1972) 1.07
[Blood levels of cephalothin in normal and impaired renal function]. Int Z Klin Pharmakol Ther Toxikol (1972) 0.96
Evaluation of an ultrasonic blood volume monitor. Nephrol Dial Transplant (1998) 0.92
Recirculation, a seemingly simple concept. Nephrol Dial Transplant (1998) 0.89
[Demonstration of mycoplasma in suprapubic vesical puncture urine (author's transl)]. Dtsch Med Wochenschr (1974) 0.89
Rheological discrimination between native, rigid and aggregated red blood cells in oscillatory flow. Biorheology (1985) 0.87
Validation of changes in extracellular volume measured during hemodialysis using a segmental bioimpedance technique. ASAIO J (1999) 0.87
Dynamics of segmental extracellular volumes during changes in body position by bioimpedance analysis. J Appl Physiol (1985) (1998) 0.87
Permeability and secondary membrane formation of a high flux polysulfone hemofilter. Kidney Int (1986) 0.86
Increasing blood flow increases kt/V(urea) and potassium removal but fails to improve phosphate removal. Clin Nephrol (2003) 0.85
Prevalence of adrenal and extra-adrenal Conn syndrome in hypertensive patients. Arch Intern Med (1996) 0.85
Predictive value of access blood flow in detecting access thrombosis. ASAIO J (1999) 0.84
p53 mutations in adrenal tumors: Caucasian patients do not show the exon 4 "hot spot" found in Taiwan. J Clin Endocrinol Metab (1996) 0.84
[Quantitative determination of total urinary protein utilizing the principle of Coomassie Brilliant Blue G250 binding to protein (author's transl)]. J Clin Chem Clin Biochem (1981) 0.83
Low-potassium and glucose-free dialysis maintains urea but enhances potassium removal. Nephrol Dial Transplant (2001) 0.83
Allergy to dialysis materials. Nephrol Dial Transplant (1989) 0.83
[Pharmacokinetics of carbenicillin in high dosage (author's transl)]. Dtsch Med Wochenschr (1974) 0.83
[In vitro studies on the mode of action and differences to heparin. Anticomplementary effect of a semisynthetic pentosan-polysulfo-ester]. Z Naturforsch B (1971) 0.82
[The physiological variability of the human sinuses (study of 500 airplane pilots)]. Fortschr Geb Rontgenstr Nuklearmed (1968) 0.82
Low-molecular-weight protein-permeable cuprammonium rayon haemofilter. Nephrol Dial Transplant (1992) 0.82
[Recent nephrologic examination methods. A critical review]. Dtsch Med Wochenschr (1972) 0.81
[Studies on the absorption and activity onset of -mehyl-digoxin in patients with atrial fibrillation]. Arzneimittelforschung (1973) 0.81
[On the question of the dissecting aneurysm in the intracranial vascular system]. Acta Neurochir (Wien) (1967) 0.81
Dissociation in the excretion of different aldosterone metabolites and unmetabolized ('free') aldosterone in hypertension. Clin Sci (Lond) (1979) 0.80
Reversible Fanconi syndrome after ingestion of a Chinese herbal 'remedy' containing aristolochic acid. Nephrol Dial Transplant (2001) 0.79
Relative underestimation of fluid removal during hemodialysis hypotension measured by whole body bioimpedance. ASAIO J (1999) 0.79
Estimation of body fluid changes during peritoneal dialysis by segmental bioimpedance analysis. Kidney Int (2000) 0.78
[Studies on the effects of various diuretics and aldosterone antagonists on renal magnesium excretion]. Verh Dtsch Ges Inn Med (1969) 0.78
Transmembranous transport and adsorption of beta-2-microglobulin during hemodialysis using polysulfone, polyacrylonitrile, polymethylmethacrylate and cuprammonium rayon membranes. Int J Artif Organs (1989) 0.78
Cardiac output and urea kinetics in dialysis patients: evidence supporting the regional blood flow model. Kidney Int (1996) 0.78
[Therapy of thallium poisoning using hemodialysis]. Dtsch Med Wochenschr (1971) 0.78
[Opisthorchis felineus--the cat liver fluke. Differential diagnosis of right-side upper abdominal pain]. Dtsch Med Wochenschr (1992) 0.78
Effect of access recirculation on the modeled urea distribution volume. Am J Kidney Dis (1996) 0.78
Keep your temper: how to avoid heat accumulation in haemodialysis. Nephrol Dial Transplant (2001) 0.77
Aldosterone metabolites and possible aldosterone precursors in hypertension. J Steroid Biochem (1983) 0.77
Human atrial natriuretic peptide (hANP) has no effect upon dopaminergic pathways: preliminary evidence in nude mice bearing heterotransplanted human CONN's adenoma tissue. Klin Wochenschr (1986) 0.77
Solute disequilibrium and multicompartment modeling. Adv Ren Replace Ther (1995) 0.77
Aldosterone diagnosis in hypertension: comparative evaluation of radioimmunoassays for urinary aldosterone and 18-OH-corticosterone. Klin Wochenschr (1978) 0.76
Effect of changes in the intravascular volume during hemodialysis on blood viscoelasticity. Indian J Nephrol (2011) 0.75
Ethylene oxide and hypersensitivity reactions in patients on hemodialysis. Kidney Int Suppl (1988) 0.75
[Bacteriological urine diagnostics]. Dtsch Med Wochenschr (1972) 0.75
[Therapy of gastric alkalosis]. Dtsch Med Wochenschr (1984) 0.75
Effects of haemodialysis on the pharmacokinetics of muzolimine. Z Kardiol (1985) 0.75
Increased excretion of 18-hydroxycorticosterone in patients with adrenal adenomas and hypertension. Clin Exp Hypertens A (1982) 0.75
[Significance of fundus evaluation in the staging of hypertensive disease compared to electrocardiography and renal circulation]. Klin Monbl Augenheilkd (1986) 0.75
When does atrial natriuretic peptide block aldosterone secretion? Lancet (1985) 0.75
Radioimmunoassay of urinary 21-deoxytetrahydroaldosterone in primary aldosteronism and 21-hydroxylase deficiency. J Steroid Biochem (1986) 0.75
Inappropriate secretion of antidiuretic hormone, polydipsia and hypothalamic calcifications. Klin Wochenschr (1989) 0.75
[Radioimmunologic determination of renin, angiotensin and aldosterone; its clinical significance]. Med Welt (1976) 0.75
[Diagnosis of adrenal tumors and adrenal hyperplasias]. Med Klin (1979) 0.75
Beta-2-microglobulin adsorption and release in-vitro: influence of membrane material, osmolality and heparin. Int J Artif Organs (1988) 0.75
Radioimmunoassays of tetrahydroaldosterone (TH-aldo) in human urine. Acta Endocrinol (Copenh) (1978) 0.75
[Hepatic artery embolization for treatment of the carcinoid syndrome]. Z Gastroenterol (1982) 0.75
[Stauffer syndrome, paraneoplastic hepatic dysfunction syndrome associated with renal cell carcinoma (author's transl)]. Urologe A (1976) 0.75
Synthesis of 19-nor-aldosterone, 18-hydroxy-19-nor-corticosterone and 18,19-dihydroxycorticosterone in the human aldosterone-producing adenoma. J Steroid Biochem Mol Biol (1990) 0.75
[Hypokalemia as the principal symptom of covert vomiting. Clinical and diagnostic aspects]. Dtsch Med Wochenschr (1987) 0.75
Direct radioimmunoassays for "aldosterone" and "18-hydroxycorticosterone" in unprocessed urine, and their use in screening to distinguish primary aldosteronism from hypertension. Clin Chem (1982) 0.75
[Clearance methods]. Med Welt (1979) 0.75
Comparison of numerical methods applied to field stimulated cardiomyocytes. Conf Proc IEEE Eng Med Biol Soc (2005) 0.75
Radioimmunoassay of free urinary 18-hydroxydeoxycorticosterone (18-OH-DOC) in patients with essential hypertension. Clin Chim Acta (1978) 0.75
Polyacrylonitrile complement activation attenuated by simultaneous ultrafiltration and adsorption. Nephrol Dial Transplant (1987) 0.75
Elimination of low molecular weight proteins with high flux membranes. Contrib Nephrol (1985) 0.75
Three cases of hemodialysis-associated hypersensitivity reactions. Int J Artif Organs (1985) 0.75
Urinary excretion of aldosterone metabolite Kelly-M1 in patients with adrenal dysfunction. J Steroid Biochem (1988) 0.75
[Indications for percutaneous kidney biopsy]. Dtsch Med Wochenschr (1972) 0.75
21-Deoxyaldosterone excretion in patients with primary aldosteronism and 21-hydroxylase deficiency. J Clin Endocrinol Metab (1987) 0.75
Urinary 18,19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone excretion in patients with primary and secondary aldosteronism. Steroids (1991) 0.75
Radioimmunoassay of tetrahydrocorticosterone (THB) in human urine. Acta Endocrinol (Copenh) (1978) 0.75
21-Deoxytetrahydroaldosterone excretion in primary hyperaldosteronism. Cardiology (1985) 0.75
[Diagnosis of gastric hypokalemic alkalosis]. Dtsch Med Wochenschr (1984) 0.75
[Pharmacokinetics of cephalothin]. Verh Dtsch Ges Inn Med (1971) 0.75
[Disorders of sodium-, potassium-, and chlorine balance]. ZFA (Stuttgart) (1977) 0.75
[Diet in hypertensive disease]. MMW Munch Med Wochenschr (1982) 0.75
Variation of ultrafiltration and dialysate sodium. Beneficial effects on vascular stability in diabetic dialysis patients. Contrib Nephrol (1989) 0.75
Elevated 'free' 18-hydroxy-corticosterone excretion as a possible indicator for early diagnosis of primary aldosteronism. J Steroid Biochem (1981) 0.75
Beta-2-microglobulin handling in dialysis. Contrib Nephrol (1989) 0.75